Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab

被引：0
|
作者：
Elliott, Elizabeth [1 ]
Waheed, Salman [2 ]
Syed, Sahr [3 ]
Eswaran, Sheila [4 ]
Gregory, Stephanie [5 ]
Shammo, Jamile [5 ]
机构：
[1] Rush Univ, Med Ctr, Dept Internal Med, 1653 W Congress Pkway, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Div Hematol & Oncol, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Sect Hepatol, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Sect Hematol, Chicago, IL 60612 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷 / 01期
关键词：
Anticomplement C5 therapy; Hemoglobinuria; Hemolysis; Iron metabolism; Iron overload; APLASTIC-ANEMIA; DIAGNOSIS; GUIDELINES; MANAGEMENT; IRON;
D O I：
10.1016/j.clml.2017.09.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E9 / E12
页数：4
相关论文
共 50 条
  • [21] Efficacy of Eculizumab in a Patient with Paroxysmal Nocturnal Hemoglobinuria Requiring Transfusions 14 Years after a Diagnosis in Childhood
    Ueda, Takahiro
    Hayakawa, Jun
    Yamanishi, Miho
    Maeda, Miho
    Fukunaga, Yoshitaka
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2013, 80 (02) : 155 - 159
  • [22] Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report
    Mandala, E.
    Lafaras, C.
    Goulis, I
    Tsioni, K.
    Georgopoulou, V
    Ilonidis, G.
    HIPPOKRATIA, 2013, 17 (01) : 81 - 84
  • [23] Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
    Quist, S. W.
    Postma, A. J.
    Myren, K. J.
    de Jong, L. A.
    Postma, M. J.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (09) : 1455 - 1472
  • [24] Successful cholecystectomy in a patient with aplastic anemia–paroxysmal nocturnal hemoglobinuria during eculizumab treatment
    Keiko Ando
    Akihiko Gotoh
    Seiichiro Yoshizawa
    Moritaka Gotoh
    Tamiko Iwabuchi
    Yoshikazu Ito
    Kazuma Ohyashiki
    Annals of Hematology, 2012, 91 : 1987 - 1988
  • [25] Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report
    Alexopoulou, Alexandra
    Mani, Iliana
    Tiniakos, Dina G.
    Kontopidou, Flora
    Tsironi, Ioanna
    Noutsou, Marina
    Pantelidaki, Helen
    Dourakis, Spyros P.
    WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (05) : 483 - 488
  • [26] Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
    S. W. Quist
    A. J. Postma
    K. J. Myrén
    L. A. de Jong
    M. J. Postma
    The European Journal of Health Economics, 2023, 24 : 1455 - 1472
  • [27] Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
    Panse, Jens Peter
    Hoechsmann, Britta
    Schubert, Joerg
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (05) : 310 - 320
  • [28] Paroxysmal nocturnal hemoglobinuria
    de Latour, R. Peffault
    Amoura, Z.
    Socie, G.
    REVUE DE MEDECINE INTERNE, 2010, 31 (03): : 200 - 207
  • [29] Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment
    Subias Hidalgo, Marta
    Martin Merinero, Hector
    Lopez, Alicia
    Anter, Jaouad
    Pinto Garcia, Sheila
    Ataulfo Gonzalez-Fernandez, Fernando
    Fores, Rafael
    Lopez-Trascasa, Margarita
    Villegas, Ana
    Ojeda, Emilio
    Rodriguez de Cordoba, Santiago
    IMMUNOBIOLOGY, 2017, 222 (02) : 363 - 371
  • [30] Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis
    Karadag, Fatma Keklik
    Yenerel, Mustafa Nuri
    Yilmaz, Mehmet
    Uskudar, Hava
    Ozkocaman, Vildan
    Tuglular, Tulin Firatli
    Erdem, Fuat
    Unal, Ali
    Ayyildiz, Orhan
    Ozet, Gulsum
    Comert, Melda
    Kaya, Emin
    Ayer, Mesut
    Salim, Ozan
    Guvenc, Birol
    Ozdogu, Hakan
    Mehtap, Ozgur
    Sonmez, Mehmet
    Guler, Nil
    Hacioglu, Sibel
    Aydogdu, Ismet
    Bektas, Ozlen
    Toprak, Selami Kocak
    Kaynar, Lale
    Yagci, Munci
    Aksu, Salih
    Tombak, Anil
    Karakus, Volkan
    Yavasoglu, Irfan
    Onec, Birgul
    Ozcan, Mehmet Ali
    Undar, Levent
    Ali, Ridvan
    Ilhan, Osman
    Saydam, Guray
    Sahin, Fahri
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (03): : 279 - 285
12345